Mayne Pharma Group Limited advised that Mr. Aaron Gray has been appointed as Chief Financial Officer (CFO), effective 29 August 2022. This follows the Company's decision to relocate the CFO role to the commercial office in Raleigh, North Carolina, USA to be co-located with the CEO and other key commercial franchises. Aaron, a USA resident based in North Carolina brings more than 20 years of experience to the role. For the last six years, Aaron has been in senior finance roles at Siemens Healthineers, a leading global medical technology company with EUR20b in revenues and 48,000 employees globally. Most recently, he was Senior Vice President - USA Customer Finance with EUR5b in revenues. Prior to Siemens Healthineers, he spent 15 years in finance roles at Siemens, AG energy divisions. Aaron has a Bachelor of Science in Finance and Master of Business Administration (MBA) from the
University of Central Florida. Mr. Peter Paltoglou will continue as CFO until the release of Mayne Pharma's fiscal year 2022 results on 26 August 2022. Peter has agreed to remain with Mayne Pharma to assist with transition until 30 September 2022.